Opportunities to optimise direct‐acting oral anticoagulants.
- Published in:
- Prescriber, 2020, v. 31, n. 10, p. 34, doi. 10.1002/psb.1874
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2020 AND VI 31 AND IP 10
Results: 7
1
2
Rybelsus: an oral formulation of the GLP‐1 agonist semaglutide.
- Published in:
- Prescriber, 2020, v. 31, n. 10, p. 32, doi. 10.1002/psb.1873
- By:
- Publication type:
- Article
3
Summary of ERS/ATS guideline on managing severe asthma.
- Published in:
- Prescriber, 2020, v. 31, n. 10, p. 27, doi. 10.1002/psb.1872
- By:
- Publication type:
- Article
4
Systemic anticancer therapies and the role of primary care.
- Published in:
- Prescriber, 2020, v. 31, n. 10, p. 22, doi. 10.1002/psb.1871
- By:
- Publication type:
- Article
5
Deprescribing antihypertensives in patients with multimorbidity.
- Published in:
- Prescriber, 2020, v. 31, n. 10, p. 16, doi. 10.1002/psb.1870
- By:
- Publication type:
- Article
6
The importance of measuring biomarkers in asthma.
- Published in:
- Prescriber, 2020, v. 31, n. 10, p. 11, doi. 10.1002/psb.1869
- By:
- Publication type:
- Article
7
New approaches to respiratory disease.
- Published in:
- Prescriber, 2020, v. 31, n. 10, p. 4, doi. 10.1002/psb.1868
- Publication type:
- Article